PubRank

Dominique Himbert

Author PubWeight™ 69.45‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010 3.79
2 Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012 2.88
3 DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction. Eur Heart J 2004 2.85
4 Unexpected complications of transapical aortic valve implantation. Ann Thorac Surg 2009 2.61
5 Multimodal assessment of the aortic annulus diameter: implications for transcatheter aortic valve implantation. J Am Coll Cardiol 2010 2.50
6 Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: analysis of 90 consecutive patients with focus on perioperative complications. J Cardiothorac Vasc Anesth 2010 2.26
7 Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly. Eur Heart J 2008 2.23
8 External validity of clinical trials in acute myocardial infarction. Arch Intern Med 2007 2.14
9 Impact of degree of commissural opening after percutaneous mitral commissurotomy on long-term outcome. JACC Cardiovasc Imaging 2009 2.05
10 Severe intraprosthetic regurgitation by immobile leaflet after trans-catheter aortic valve implantation. Eur J Cardiothorac Surg 2010 2.04
11 One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011 1.98
12 One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 2010 1.63
13 Early and mid-term outcomes in patients undergoing transcatheter aortic valve implantation after previous coronary artery bypass grafting. Eur J Cardiothorac Surg 2011 1.58
14 Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. JACC Cardiovasc Interv 2009 1.48
15 Long-term clinical outcomes after rescue angioplasty are not different from those of successful thrombolysis for acute myocardial infarction. Eur Heart J 2005 1.47
16 Universal reperfusion therapy can be implemented: lessons from 20 years of management of patients admitted within 6 hours of symptom onset with ST-segment elevation acute myocardial infarction. Arch Cardiovasc Dis 2009 1.38
17 Impact of coronary artery disease on indications for transcatheter aortic valve implantation and on procedural outcomes. EuroIntervention 2011 1.26
18 Acute coronary angiographic findings in survivors of out-of-hospital cardiac arrest. Am Heart J 2008 1.26
19 Enhanced shear-induced platelet aggregation in patients who experience subacute stent thrombosis: a case-control study. J Am Coll Cardiol 2005 1.19
20 Relation of mortality of primary angioplasty during acute myocardial infarction to door-to-Thrombolysis In Myocardial Infarction (TIMI) time. Am J Cardiol 2003 1.19
21 Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation. Am J Cardiol 2012 1.12
22 Measurement of aortic valve calcification using multislice computed tomography: correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction. Heart 2010 1.06
23 Anesthesia and perioperative management of patients who undergo transfemoral transcatheter aortic valve implantation: an observational study of general versus local/regional anesthesia in 125 consecutive patients. J Cardiothorac Vasc Anesth 2011 1.03
24 Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome. EuroIntervention 2010 0.98
25 Transcatheter valve-in-ring implantation after failure of surgical mitral repair. Eur J Cardiothorac Surg 2013 0.96
26 Mitral regurgitation in patients referred for transcatheter aortic valve implantation using the Edwards Sapien prosthesis: mechanisms and early postprocedural changes. J Am Soc Echocardiogr 2011 0.93
27 Changing demographics of valvular heart disease and impact on surgical and transcatheter valve therapies. Int J Cardiovasc Imaging 2011 0.92
28 Evaluation of mitral stenosis in 2008. Arch Cardiovasc Dis 2008 0.92
29 Myocardial infarction after blunt chest trauma: usefulness of cardiac ECG-gated CT and MRI for positive and aetiologic diagnosis. Emerg Radiol 2011 0.91
30 Reappraisal of percutaneous aortic balloon valvuloplasty as a preliminary treatment strategy in the transcatheter aortic valve implantation era. EuroIntervention 2011 0.89
31 Transcatheter aortic valve implantation: selection strategy is crucial for outcome. Ann Thorac Surg 2009 0.88
32 Transfemoral implantation of an Edwards SAPIEN valve in a tricuspid bioprosthesis without fluoroscopic landmarks. EuroIntervention 2012 0.86
33 Usefulness of left atrial volume versus diameter to assess thromboembolic risk in mitral stenosis. Am J Cardiol 2010 0.84
34 Immediate and mid-term results of transfemoral aortic valve implantation using either the Edwards Sapien transcatheter heart valve or the Medtronic CoreValve System in high-risk patients with aortic stenosis. Arch Cardiovasc Dis 2010 0.82
35 Initial French experience of percutaneous mitral valve repair with the MitraClip: a multicentre national registry. Arch Cardiovasc Dis 2013 0.81
36 Impact of previous cardiovascular disease on the outcome of lung transplantation. J Heart Lung Transplant 2010 0.81
37 Transcatheter aortic valve implantation: could it be done without prior balloon valvuloplasty? JACC Cardiovasc Interv 2011 0.80
38 Transcatheter aortic valve implantation: a treatment we are going to need! J Am Coll Cardiol 2013 0.80
39 Balloon expandable transcatheter heart valves for native mitral valve disease with severe mitral annular calcification. J Cardiovasc Surg (Torino) 2016 0.79
40 Age and lack of beta-blocker therapy are associated with increased long-term mortality after primary coronary angioplasty for acute myocardial infarction. Int J Cardiol 2003 0.79
41 Reversible Edwards Sapien XT dysfunction due to prosthesis thrombosis presenting as early structural deterioration. J Am Coll Cardiol 2012 0.79
42 Mechanisms and management of TAVR-related complications. Nat Rev Cardiol 2013 0.79
43 Multicenter evaluation of Edwards SAPIEN positioning during transcatheter aortic valve implantation with correlates for device movement during final deployment. JACC Cardiovasc Interv 2012 0.79
44 Long-term efficacy of percutaneous mitral commissurotomy for restenosis after previous mitral commissurotomy. Heart 2013 0.78
45 Reinterventions after percutaneous mitral commissurotomy during long-term follow-up, up to 20 years: the role of repeat percutaneous mitral commissurotomy. Eur Heart J 2013 0.78
46 Understanding risk assessment in cardiac surgery patients. Semin Thorac Cardiovasc Surg 2010 0.77
47 Transcatheter valve replacement in patients with severe mitral valve disease and annular calcification. J Am Coll Cardiol 2014 0.77
48 Transcatheter aortic valve replacement: current application and future directions. Curr Cardiol Rep 2013 0.77
49 Unmet clinical needs in transcatheter mitral valve interventions in 2014. EuroIntervention 2014 0.77
50 Transcatheter Aortic Valve Replacement to Treat Pure Aortic Regurgitation on Noncalcified Native Valves. J Am Coll Cardiol 2016 0.76
51 False aneurysm after transapical aortic valve implantation. J Thorac Cardiovasc Surg 2008 0.76
52 Comparison of hospital mortality during ST-segment elevation myocardial infarction in the era of reperfusion therapy in women versus men and in older versus younger patients. Am J Cardiol 2013 0.76
53 Multiple valve disease - assessment, strategy and intervention. EuroIntervention 2015 0.76
54 Mitral leaflet separation index: a new method for the evaluation of the severity of mitral stenosis? Usefulness before and after percutaneous mitral commissurotomy. J Am Soc Echocardiogr 2007 0.76
55 Transcatheter aortic valve implantation: our vision of the future. Arch Cardiovasc Dis 2012 0.76
56 How should I treat a severely symptomatic, high-risk female patient with degenerated mitral (Carpentier-Edwards porcine) and aortic (Sorin Mitroflow) bioprostheses? EuroIntervention 2015 0.76
57 A step forward in the evaluation of transcatheter aortic valve implantation. J Am Coll Cardiol 2010 0.75
58 Transcatheter aortic valve implantation: a snapshot from the United Kingdom. J Am Coll Cardiol 2011 0.75
59 Compassionate aortic valve implantation for severe aortic regurgitation. J Thorac Cardiovasc Surg 2010 0.75
60 Atrial fibrillation following transcatheter aortic valve implantation: do we underestimate its frequency and impact? J Am Coll Cardiol 2011 0.75
61 Transvenous mitral valve replacement after failure of surgical ring annuloplasty. J Am Coll Cardiol 2012 0.75
62 Percutaneous mitral valve repair: the beginning of the end or the end of the beginning? F1000 Med Rep 2010 0.75
63 Real-time 3D transoesophageal measurement of the mitral valve area in patients with mitral stenosis. Eur J Echocardiogr 2011 0.75
64 'Valve-in-valve' implantation in a patient with degenerated aortic bioprosthesis and severe regurgitation. Eur Heart J 2009 0.75
65 Alcohol septal ablation preceding transcatheter valve implantation to prevent left ventricular outflow tract obstruction. EuroIntervention 2017 0.75
66 Late Displacement After Transcatheter Mitral Valve Replacement for Degenerative Mitral Valve Disease With Massive Annular Calcification. JACC Cardiovasc Interv 2016 0.75
67 Percutaneous valve procedures: present and future. Int J Cardiovasc Intervent 2005 0.75
68 Transfemoral valve-in-ring implantation for a failing mitral homograft in the tricuspid position. EuroIntervention 2014 0.75
69 How should I treat refractory cardiogenic shock in a patient with chronic biventricular heart failure and mitral regurgitation with difficult valve characteristics? EuroIntervention 2016 0.75
70 Delayed migration of a transfemorally implanted aortic bioprosthesis. J Thorac Cardiovasc Surg 2011 0.75
71 Transarterial Medtronic CoreValve system implantation for degenerated surgically implanted aortic prostheses. Circ Cardiovasc Interv 2011 0.75
72 Late results of percutaneous mitral commissurotomy up to 20 years: development and validation of a risk score predicting late functional results from a series of 912 patients. Circulation 2012 0.75
73 Management of Radiation-Induced Valvular Heart Disease due to Hodgkin's Lymphoma in the Modern Area. EuroIntervention 2017 0.75
74 Valve Thrombosis After Transcatheter Mitral Valve Replacement. J Am Coll Cardiol 2016 0.75
75 Suprasternal Brachiocephalic Approach as an Alternative Route for Transcatheter Aortic Valve Implantation: a Single-Center Experience. EuroIntervention 2016 0.75
76 "Valve-in-valve" implantation in a patient with stentless bioprosthesis and severe intraprosthetic aortic regurgitation. J Thorac Cardiovasc Surg 2009 0.75
77 Transcatheter valve implantation for patients with aortic stenosis. Heart 2010 0.75
78 Successful endovascular stroke rescue with retrieval of an embolized calcium fragment after transcatheter aortic valve replacement. Circ Cardiovasc Interv 2014 0.75
79 [What's new in cardiology]. Rev Prat 2016 0.75
80 Tools and Techniques - Clinical: Embolic protection devices in transcatheter aortic valve implantation. EuroIntervention 2015 0.75
81 How should I treat prosthetic tricuspid stenosis in an extreme surgical risk patient? EuroIntervention 2013 0.75
82 Emergency transseptal transcatheter mitral valve-in-valve implantation. EuroIntervention 2013 0.75
83 Five-year haemodynamic outcomes of the first-generation SAPIEN balloon-expandable transcatheter heart valve. EuroIntervention 2016 0.75